Yoichi Shimizu
Overview
Explore the profile of Yoichi Shimizu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kitano Y, Miyake K, Shimizu Y, Kawashima M, Nakamoto Y
Clin Nucl Med
. 2025 Jan;
PMID: 39848225
A 59-year-old woman with cT3N3M1 invasive breast cancer (ER low positive, PgR positive, HER2 negative) underwent PET/CT and dedicated breast PET scans using 18F-FDG and 18F-fluoroestradiol (18F-FES). While most primary...
2.
Gotoh R, Shimizu Y, Hayashi A, Isseki M, Miura T, Inoue A, et al.
Am J Hosp Palliat Care
. 2025 Jan;
10499091241313299.
PMID: 39772777
Anticipatory grief is associated with post-bereavement grief; however, reports on the influence of pre-loss depression are limited. Therefore, we investigated the association between the anticipatory grief of family members and...
3.
Shimizu Y, Hayashi A, Maeda I, Miura T, Inoue A, Takano M, et al.
Palliat Support Care
. 2024 Oct;
23():e12.
PMID: 39439089
Objectives: Coping styles can be improved by dyadic palliative care interventions and may alleviate patients' and family caregivers' distress. Moreover, family caregivers' preloss resilience protects against depression after bereavement. This...
4.
Nakano K, Kanno Y, Kajiwara K, Kobayashi M, Morikawa M, Matsuda Y, et al.
J Palliat Med
. 2024 Jul;
28(1):115-122.
PMID: 39069892
Constipation is an uncomfortable symptom experienced by many patients with advanced cancer, and it decreases the quality of life. Several studies have advised pharmacological therapies for constipation management, whereas others...
5.
Shimizu Y, Ando M, Watanabe H, Ono M
Ann Nucl Med
. 2024 Jul;
38(10):847-851.
PMID: 38976087
Objective: Prostate-specific membrane antigen (PSMA) is a well-known biomarker of prostate cancer. Previously, our group reported that the succinimidyl-cystatin-urea-glutamate (SCUE) moiety has a high affinity for PSMA. In this study,...
6.
Otani D, Murakami T, Murakami S, Hanaoka I, Fujimoto H, Shimizu Y, et al.
Endocr J
. 2024 Jun;
71(9):925-933.
PMID: 38839345
Insulinomas are the most common functional pancreatic neuroendocrine neoplasm; when treatment is delayed, they induce hyperinsulinemic hypoglycemia, which is life-threatening. As surgical resection is the only curative treatment for insulinoma,...
7.
Kako J, Kajiwara K, Kobayashi M, Kanno Y, Morikawa M, Nakano K, et al.
Am J Hosp Palliat Care
. 2024 Apr;
42(2):145-154.
PMID: 38580325
Background: This report investigates the applicability of nursing support for patients with cancer with a prognosis of months and weeks, and their families. Objectives: To evaluate the applicability of nursing...
8.
Morikawa M, Kajiwara K, Kobayashi M, Yusuke K, Nakano K, Matsuda Y, et al.
Cureus
. 2024 Jan;
15(11):e49692.
PMID: 38161938
Pain is subjective, warranting tailored responses in pharmacotherapy and nursing support. Despite this, the evidence for suitable nursing support for pain is not well established in terminally ill patients such...
9.
Kobayashi M, Kajiwara K, Morikawa M, Kanno Y, Nakano K, Matsuda Y, et al.
Cureus
. 2023 Dec;
15(11):e48212.
PMID: 38050521
Nausea and vomiting are symptoms commonly experienced by patients with advanced cancer and have a wide range of causes, including pharmacological interventions. Additionally, multiple factors often simultaneously cause nausea and...
10.
Kajiwara K, Kobayashi M, Morikawa M, Kanno Y, Nakano K, Matsuda Y, et al.
Am J Hosp Palliat Care
. 2023 Nov;
41(10):1184-1194.
PMID: 37963324
To identify nursing support for caregiver burden in family caregivers of patients with cancer. This scoping review was guided by Arksey and O'Malley's six-stage scoping review framework. All available published...